ScholarIQanswers from OpenAlex
Upadacitinib for Moderate to Severe Atopic Dermatitis
PaperCitations, authors & open-access status
Upadacitinib for Moderate to Severe Atopic Dermatitis is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Upadacitinib for Moderate to Severe Atopic Dermatitis have?
ScholarIQcitation count
Upadacitinib for Moderate to Severe Atopic Dermatitis has 15 citations in the OpenAlex counts ScholarIQ stores.
When was Upadacitinib for Moderate to Severe Atopic Dermatitis published?
ScholarIQyear
Upadacitinib for Moderate to Severe Atopic Dermatitis has 2023 year in the ScholarIQ index.
What is the open-access status of Upadacitinib for Moderate to Severe Atopic Dermatitis?
ScholarIQoa status
Upadacitinib for Moderate to Severe Atopic Dermatitis has closed oa status in the ScholarIQ index.
What is the DOI of Upadacitinib for Moderate to Severe Atopic Dermatitis?
ScholarIQdoi
The DOI for Upadacitinib for Moderate to Severe Atopic Dermatitis is on the source record.
What is the PMID of Upadacitinib for Moderate to Severe Atopic Dermatitis?
ScholarIQpmid
The PMID for Upadacitinib for Moderate to Severe Atopic Dermatitis is on the source record.
What is the OpenAlex record for Upadacitinib for Moderate to Severe Atopic Dermatitis?
ScholarIQopenalex
The OpenAlex for Upadacitinib for Moderate to Severe Atopic Dermatitis is on the source record.